Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Østensen, M
Right arrow Articles by Villiger, P M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Østensen, M
Right arrow Articles by Villiger, P M
Annals of the Rheumatic Diseases 2004;63:1212-1217
© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism


EXTENDED REPORT

A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments

M Østensen , L Fuhrer , R Mathieu , M Seitz , P M Villiger

Department of Rheumatology and Clinical Immunology/Allergy, University Hospital of Berne, Berne, Switzerland

Correspondence to:
Correspondence to:
Professor M Østensen
Department of Rheumatology and Clinical Immunology and Allergy, University Hospital, CH-3010 Bern, Switzerland; monika.oestensen{at}insel.ch

Objective: : To analyse the disease course of patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) during and after pregnancy by validated clinical instruments for measurement of disease activity, and assess their usefulness in pregnant patients.

Methods: Included were 10 patients with RA and 9 with AS (10 pregnancies). Clinical examination and blood/urine sampling was performed before conception, at each trimester, and weeks 6, 12, and 24 post partum. Assessment of RA was by the RA Disease Activity Index (RADAI), the 44 joint count, and the Health Assessment Questionnaire; assessment of AS by the Bath Ankylosing Spondylitis Activity Index (BASDAI), the Dougados Functional and Articular Index, and a night pain index. Common for all patients were the patient’s and physician’s global assessment.

Results: : Most patients with RA showed sustained or increased improvement of disease activity during pregnancy. Higher disease activity scores were found in the patients with AS with a frequent increase of disease activity in the second trimester and mitigation of symptoms in the third trimester. Analysis specifically for the patient’s assessment of pain showed continuously higher pain scores in the patients with AS than in those with RA. Rank correlation showed good to moderate correlation between most clinical measurements and RADAI or BASDAI, respectively. Functional indices were confounded by physiological changes of late pregnancy.

Conclusion: RA can be monitored during and after pregnancy by the swollen joint count and RADAI without interference from pregnancy related symptoms, whereas usual measures of disease activity are not always applicable in pregnant patients with AS.


Abbreviations: AS, ankylosing spondylitis; ASAS, Ankylosing Spondylitis Assessment; BASDAI, Bath Ankylosing Spondylitis Activity Index; CRP, C reactive protein; DAI, Dougados Articular Index; DFI, Dougados Functional Index; DMARDs, disease modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; NSAIDs, non-steroidal anti-inflammatory drugs; RA, rheumatoid arthritis; RADAI, RA Disease Activity Index

Keywords: rheumatoid arthritis; ankylosing spondylitis; pregnancy; assessment of disease activity




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
F Forger, N Marcoli, S Gadola, B Moller, P M Villiger, and M Ostensen
Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis
Ann Rheum Dis, July 1, 2008; 67(7): 984 - 990.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Haupl, M. Ostensen, A. Grutzkau, G.-R. Burmester, and P. M. Villiger
Interaction between rheumatoid arthritis and pregnancy: correlation of molecular data with clinical disease activity measures
Rheumatology, June 1, 2008; 47(suppl_3): iii19 - iii22.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Gayed and C. Gordon
Pregnancy and rheumatic diseases
Rheumatology, November 1, 2007; 46(11): 1634 - 1640.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F Forger, M Ostensen, A Schumacher, and P M Villiger
Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 health survey
Ann Rheum Dis, October 1, 2005; 64(10): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Ostensen, P Sicher, F Forger, and P M Villiger
Activation markers of peripheral blood mononuclear cells in late pregnancy and after delivery: a pilot study
Ann Rheum Dis, February 1, 2005; 64(2): 318 - 320.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & European League Against Rheumatism